Whew, New day. First day at a new school is always rough.
Whew, New day. First day at a new school is always rough.
So the reality is, no one saw "that" coming. Yes there are those that will preach they did, but no, they didn't...unless they were a part of the selling or knew who did it.
Institutional investors would have demanded a even lower price if they had any calculation the price was going to get hit like that, so the smartest and most discerning investors didn't see it coming.
The volume was stunning. And for me very very reassuring!
If we dropped and volume was anemic that would have concerned me.
Pre-Market was off the charts.
The other week when Rory filed the S1-A and the price took that hit, it evened out nicely and quite quickly.
Can't say "it will" do the same, but I'd be mindboggled if it didn't.
Unsure if there are more share out there to be "dumped" or not.
We will see and see what volume has in store for us.
Monday - at least 1 PR announcing the Opening Bell Ringing Friday
Tuesday - closing - so mayby a PR announcing that or
Wednesday - the Announcment of the deal closing
- when does Rory begin giving guidance? Once SC and VERB are one, their Revenue becomes our rev and numbers become far easier to announces for VERB.
Friday - Opening Bell Ringing, with tons and tons of Pub!
Not to mention all of the other integrations and deals that be will be announced in the coming weeks and months.
Rory promised us NASDAQ and he delivered.
We are now in the Big Leagues, where valuations and projections will be understood by analysts and "The Markert".
I am grateful for Rory and his drive and all of #teamVERB!!!
And remember, most of them have been paid in shares.
My money is on them and for good reason.
Have a good weekend and just know we are in a better place right now.
Inst. long term Investors
On NASDAQ
Closing of SC deal
Opening Bell Ringing
Guidance coming with real meaty revenue
Debt free
Intergration announcements
Standing next to being compared to all the heavy hitters up here.
A new audience that will care what those PR's mean.
Think of it as we are that walk on that no one had heard of but once people see what VERB can do, everyone will want a piece....
Much Aloha
22
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...
Continue Reading
Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...
Continue Reading
An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...
Continue Reading
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...
Continue Reading
Top 5 Most Recently Viewed Articles
Eli Lilly's New Ventures to Boost Drug Development Eli Lilly and Co (NYSE: LLY) has announced a significant investment of $4.5 billion for establishing the Lilly Medicine Foundry, a cutting-edge research and manufacturing facility. This initiative aims to enhance the company's drug pipeline and facilitate faster delivery of treatments to the market. The investment is a...
Continue Reading
Innovative Machinery Companies Selected for Global Support Program The Korea Innovation Foundation (INNOPOLIS) has recently announced the selection of three innovative machinery companies for its Global Technology Commercialization Support Program. The companies chosen are ARA, Korea Intelligence Machine, and Moqous, each recognized for their unique contributions to...
Continue Reading
Understanding Oracle's Position in the Software Industry In the bustling and ever-evolving world of technology, staying informed about company dynamics is more crucial than ever. For both investors and enthusiasts, comprehensively analyzing players like Oracle (NYSE: ORCL) can unveil significant insights. This article embarks on a detailed exploration of Oracle's...
Continue Reading
Sono-Tek Secures Major Order in Medical Device Sector Sono-Tek Corporation, a leading name in ultrasonic coating systems, has recently announced an impressive order worth over $2.8 million from a notable medical device manufacturer. This order signifies the trust and confidence that industry leaders place in Sono-Tek as they enhance their production capabilities. Details...
Continue Reading
Moderna's Sales Decline: A Closer Look This past week, Moderna Inc. (NASDAQ: MRNA) experienced a setback as it reported its fourth-quarter earnings, highlighting a significant loss in earnings per share (EPS). The company posted an EPS loss of $(2.91), which fell short of the projected $(2.62) and marked a downturn from a positive EPS of $0.55 in the same quarter last...
Continue Reading